1020 1st Ave
King of Prussia , PA 19406
About CSL Behring
It began with a promise. CSL Behring's parent company, CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Our ability to innovate and deliver life-saving medicines for patients with rare disease and other unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL Behring and we are driven by our promise.
David Karas, Area Manager - Immunology
Lynn Tomko, Area Manager - Immunology
Bria Gibbs, Area Manager - Immunology
Jaclyn Elich, Area Manager - Immunology
Kristine Sambuco, Area Manager - Immunology
Representatives will be available to meet with attendees at the following times:
Hizentra is an IG therapy that provides proven protection for Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with the convenience of self-administration, so you can focus on everyday living.